BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.630
-0.040 (-1.50%)
At close: Mar 16, 2026, 4:00 PM EDT
2.602
-0.028 (-1.07%)
After-hours: Mar 16, 2026, 6:28 PM EDT

Revenue by Segment

Millions ILA. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '10 Dec '09
License
17.00M
Oncology and Hematology
700.72K
Oncology and Hematology Growth
-99.38%

Revenue by Geography

Millions ILA. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '10 Dec '09
Israel
17.70M
Israel Growth
-84.36%